$2 million SBIR grant fast-tracks cancer drug platform technology

(Purdue University) A $1,999,998 SBIR Phase I/II grant from the National Institute of Cancer to KinaRx LLC, a Purdue University-affiliated startup, will help fast-track to human trials a novel platform aimed at treating relapse for acute myeloid leukemia and other diseases.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news